Literature DB >> 17387387

Genomic alterations in low-grade, anaplastic astrocytomas and glioblastomas.

Ali Arslantas1, Sevilhan Artan, Ulkü Oner, M Hamza Müslümanoglu, Muhsin Ozdemir, Ramazan Durmaz, Didem Arslantas, Murat Vural, Erhan Cosan, Metin Ant Atasoy.   

Abstract

To extend our understanding of potential stepwise genetic alterations that may underlie tumor progression from low-grade astrocytomas to glioblastomas, histopathologic and comparative genomic hybridization analyses were performed on tumor specimens from 68 primary lesions, including 40 glioblastomas, 10 anaplastic and 18 low-grade astrocytomas. The number of aberrations per case increased towards the higher grade tumors (grade II: 1.66+/-1.49; grade III: 2.80+/-1.68; grade IV: 3.02+/-1.07; F=6.955, p=0.002). A gain of 7/7q was common and the most frequently seen aberration in low-grade astrocytomas, whereas loss of 10q was the most frequently seen anomaly in anaplastic astrocytomas and glioblastomas. Chromosome 7p amplification was only detected in glioblastomas. Chromosome 10/10q deletion and combination of 1p, 19q and 17p deletions were specific to high-grade astrocytic tumors. Sequences of chromosome 7 and 10 seem to have pivotal roles in the biology of human gliomas. The genomic copy deletions of chromosomes 1p and 19q might provide an alternative mechanism in the genesis of astrocytomas.

Entities:  

Mesh:

Year:  2007        PMID: 17387387     DOI: 10.1007/bf02893439

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  29 in total

Review 1.  Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization.

Authors:  T Nishizaki; S Ozaki; K Harada; H Ito; H Arai; T Beppu; K Sasaki
Journal:  Genes Chromosomes Cancer       Date:  1998-04       Impact factor: 5.006

2.  Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.

Authors:  S H Bigner; M R Matthews; B K Rasheed; R N Wiltshire; H S Friedman; A H Friedman; T T Stenzel; D M Dawes; R E McLendon; D D Bigner
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

Review 3.  Correlation of molecular genetic analysis of p53, MDM2, p16, PTEN, and EGFR and survival of patients with anaplastic astrocytoma and glioblastoma.

Authors:  Yukitaka Ushio; Kenji Tada; Shoji Shiraishi; Takanori Kamiryo; Naoki Shinojima; Masato Kochi; Hideyuki Saya
Journal:  Front Biosci       Date:  2003-05-01

4.  Grade II astrocytomas are subgrouped by chromosome aberrations.

Authors:  Yuichi Hirose; Kenneth D Aldape; Susan Chang; Kathleen Lamborn; Mitchel S Berger; Burt G Feuerstein
Journal:  Cancer Genet Cytogenet       Date:  2003-04-01

5.  Impact of genotype and morphology on the prognosis of glioblastoma.

Authors:  Matthias C Schmidt; Sven Antweiler; Nina Urban; Wolf Mueller; A Kuklik; Birgit Meyer-Puttlitz; Otmar D Wiestler; David N Louis; Rolf Fimmers; Andreas von Deimling
Journal:  J Neuropathol Exp Neurol       Date:  2002-04       Impact factor: 3.685

6.  Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.

Authors:  Ali Arslantas; Sevilhan Artan; Ulkü Oner; Ramazan Durmaz; Hamza Müslümanoğlu; Metin Ant Atasoy; Nurettin Başaran; Eşref Tel
Journal:  Acta Neurol Belg       Date:  2002-06       Impact factor: 2.396

7.  Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10.

Authors:  A E Karlbom; C D James; J Boethius; W K Cavenee; V P Collins; M Nordenskjöld; C Larsson
Journal:  Hum Genet       Date:  1993-09       Impact factor: 4.132

8.  Detection of chromosomal imbalances in spinal meningiomas by comparative genomic hybridization.

Authors:  Ali Arslantas; Sevilhan Artan; Ulkü Oner; Ramazan Durmaz; Hamza Müslümanoglu; Metin Ant Atasoy; Nurettin Başaran; Eşref Tel
Journal:  Neurol Med Chir (Tokyo)       Date:  2003-01       Impact factor: 1.742

9.  Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q.

Authors:  A von Deimling; B Bender; R Jahnke; A Waha; J Kraus; S Albrecht; R Wellenreuther; F Fassbender; J Nagel; A G Menon
Journal:  Cancer Res       Date:  1994-03-15       Impact factor: 12.701

10.  Chromosomal abnormalities in human glioblastomas: gain in chromosome 7p correlating with loss in chromosome 10q.

Authors:  María del Mar Inda; Xing Fan; Jorge Muñoz; Christine Perot; Didier Fauvet; Giselle Danglot; Ana Palacio; Pilar Madero; Idoya Zazpe; Eduardo Portillo; Teresa Tuñón; José María Martínez-Peñuela; Jorge Alfaro; José Eiras; Alain Bernheim; Javier S Castresana
Journal:  Mol Carcinog       Date:  2003-01       Impact factor: 4.784

View more
  12 in total

1.  Gene expression profiles of human glioblastomas are associated with both tumor cytogenetics and histopathology.

Authors:  Ana Luísa Vital; Maria Dolores Tabernero; Abel Castrillo; Olinda Rebelo; Hermínio Tão; Fernando Gomes; Ana Belen Nieto; Catarina Resende Oliveira; Maria Celeste Lopes; Alberto Orfao
Journal:  Neuro Oncol       Date:  2010-05-18       Impact factor: 12.300

2.  Glutamate promotes cell growth by EGFR signaling on U-87MG human glioblastoma cell line.

Authors:  Daniel Pretto Schunemann; Ivana Grivicich; Andréa Regner; Lisiane Freitas Leal; Daniela Romani de Araújo; Geraldo Pereira Jotz; Carlos Alexandre Fedrigo; Daniel Simon; Adriana Brondani da Rocha
Journal:  Pathol Oncol Res       Date:  2009-12-08       Impact factor: 3.201

Review 3.  Exosomes as Tools to Suppress Primary Brain Tumor.

Authors:  Mark Katakowski; Michael Chopp
Journal:  Cell Mol Neurobiol       Date:  2016-03-17       Impact factor: 5.046

4.  Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis.

Authors:  Carsten Hagemann; Steffen Fuchs; Camelia M Monoranu; Pia Herrmann; Janice Smith; Tim Hohmann; Urszula Grabiec; Almuth F Kessler; Faramarz Dehghani; Mario Löhr; Ralf-Ingo Ernestus; Giles H Vince; Ulrike Stein
Journal:  Neuro Oncol       Date:  2013-11-11       Impact factor: 12.300

5.  A sensitive and specific diagnostic panel to distinguish diffuse astrocytoma from astrocytosis: chromosome 7 gain with mutant isocitrate dehydrogenase 1 and p53.

Authors:  Sandra Camelo-Piragua; Michael Jansen; Aniruddha Ganguly; James ChulMin Kim; Arjola K Cosper; Dora Dias-Santagata; Catherine L Nutt; A John Iafrate; David N Louis
Journal:  J Neuropathol Exp Neurol       Date:  2011-02       Impact factor: 3.148

6.  Molecular-genetic and clinical characteristics of gliomas with astrocytic appearance and total 1p19q loss in a single institutional consecutive cohort.

Authors:  Saeko Hayashi; Hikaru Sasaki; Tokuhiro Kimura; Takayuki Abe; Takumi Nakamura; Yohei Kitamura; Tomoru Miwa; Kaori Kameyama; Yuichi Hirose; Kazunari Yoshida
Journal:  Oncotarget       Date:  2015-06-30

Review 7.  The Role of Mir-148a in Cancer.

Authors:  Yue Li; Xiyun Deng; Xiaomin Zeng; Xiaoning Peng
Journal:  J Cancer       Date:  2016-06-21       Impact factor: 4.207

8.  Distinct genomic aberrations between low-grade and high-grade gliomas of Chinese patients.

Authors:  Yunbo Li; Dapeng Wang; Lei Wang; Jinhai Yu; Danhua Du; Ye Chen; Peng Gao; Duen-Mei Wang; Jun Yu; Feng Zhang; Shuanglin Fu
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

9.  Genetic alterations in glioma.

Authors:  Linda B C Bralten; Pim J French
Journal:  Cancers (Basel)       Date:  2011-03-07       Impact factor: 6.639

10.  Metastasis-associated in colon cancer 1 is a novel survival-related biomarker for human patients with renal pelvis carcinoma.

Authors:  Hailong Hu; Dawei Tian; Tao Chen; Ruifa Han; Yan Sun; Changli Wu
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.